| 31 Aug, 09:07 pm | regulatory_action | 1 | Sanofi India received a GST show cause notice alleging misclassification of products for FY2020-21, proposing a tax liability and penalty of Rs 36.39 crore each (total Rs 72.77 crore), which the company does not expect to adversely impact its financials. | nse |
| 13 Aug, 11:57 am | — | … | Please find enclosed intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | nse |
| 11 Aug, 01:24 pm | — | … | Please find enclosed intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | nse |
| 10 Aug, 01:13 pm | — | … | Sanofi India Limited has informed the Exchange about Transcript of Investor / Analysts Call. | nse |
| 10 Aug, 01:04 pm | — | … | Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 06 Aug, 11:25 am | — | … | Sanofi India Limited has informed the Exchange about Link of Video Recording of Investor / Analysts Call | nse |
| 06 Aug, 11:20 am | — | … | Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 05 Aug, 01:14 pm | — | … | Sanofi India Limited has informed the Exchange about copies of Newspaper Publication of Financial Results for the quarter and half year ended 30th June 2026 | nse |
| 05 Aug, 01:13 pm | — | … | Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 05 Aug, 01:11 pm | — | … | Sanofi India Limited has informed the Exchange about Investor / Analysts Call - Presentation | nse |
| 04 Aug, 08:31 pm | — | … | Sanofi India Limited has informed the Exchange about Intimation Under Regulation 30(5) Of the Listing Regulations | nse |
| 04 Aug, 08:29 pm | — | … | Sanofi India Limited has informed the Exchange about Re-constitution of the Committees of the Company. | nse |
| 04 Aug, 08:24 pm | — | … | Sanofi India Limited has informed the Exchange regarding a press release dated August 04, 2026, titled "Sanofi India delivers strong Q2 2026 performance, Led by double digit growth in Diabetes Portfolio and a Robust Profit Momentum". | nse |
| 04 Aug, 08:21 pm | — | … | Sanofi India Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. | nse |
| 04 Aug, 08:15 pm | — | … | Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 04 Aug, 08:13 pm | — | … | Sanofi India Ltd - 500674 - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2026 | bse |
| 04 Aug, 08:10 pm | — | … | Sanofi India Ltd - 500674 - Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2026 | bse |
| 31 Jul, 02:51 pm | — | … | Sanofi India Limited has informed the Exchange about change in Senior Management Personnel Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | nse |
| 23 Jul, 12:40 pm | — | … | Sanofi India Limited has informed the Exchange about Resignation of Director/KMP/SMP | nse |
| 23 Jul, 10:45 am | — | … | Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Resignation of Director | bse |
| 23 Jul, 10:39 am | — | … | Sanofi India Limited has informed the Exchange regarding Resignation of Mr Rachid Ayari as Whole Time Director and Chief Financial Officer of the Company w.e.f. September 30, 2026. | nse |
| 23 Jul, 10:35 am | — | … | Sanofi India Limited has informed the Exchange regarding resignation of Mr Rachid Ayari as Chief Financial Officer of the Company with effect from the close of business hours on 30th September 2026 | nse |
| 23 Jul, 10:30 am | — | … | Sanofi India Limited has informed the Exchange about change in Management | nse |
| 23 Jul, 10:29 am | — | … | Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | bse |
| 23 Jul, 10:28 am | — | … | Sanofi India Limited has informed the Exchange regarding Change in Director(s) of the company. | nse |
| 23 Jul, 10:22 am | — | … | Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 23 Jul, 10:20 am | — | … | Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 20 Jul, 12:18 pm | — | … | Sanofi India Ltd - 500674 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2026. | bse |
| 03 Jul, 10:52 am | — | … | Sanofi India Limited has informed the Exchange about disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | nse |
| 24 Jun, 04:36 pm | — | … | Sanofi India Limited has informed the Exchange about disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | nse |
| 15 Jun, 02:43 pm | — | … | Sanofi India Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | nse |
| 09 Jun, 07:14 pm | procedural | 0 | Enclosed an unspecified Regulation 30 intimation under SEBI LODR, 2015 with no investment-relevant details provided in the text. | nse |
| 03 Jun, 12:12 pm | — | … | Sanofi India Limited has informed the Exchange about appointment of Mr. Debajit Roy as Sales & Customer Engagement Head Diabetes of the Company. | nse |
| 03 Jun, 12:11 pm | — | … | Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 27 May, 11:49 am | — | … | Please find enclosed intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | nse |
| 30 Apr, 04:27 pm | — | … | Sanofi India Limited has informed the Exchange regarding a press release dated April 30, 2026, titled "Please find enclosed Press Release dated 30th April 2026.". | nse |
| 30 Apr, 04:22 pm | — | … | Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 28 Apr, 07:07 pm | — | … | Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 28 Apr, 07:04 pm | — | … | Sanofi India Limited has informed the Exchange regarding Appointment of Mr. Rahul Bhatnagar as Chairman of the company w.e.f. April 30, 2026. | nse |
| 28 Apr, 06:51 pm | — | … | Sanofi India Limited has informed the Exchange regarding Change in Director(s) of the company. | nse |
| 28 Apr, 06:51 pm | — | … | Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 28 Apr, 06:46 pm | — | … | Sanofi India Ltd - 500674 - Results For The Quarter Ended 31St March 2026 | bse |
| 28 Apr, 06:44 pm | — | … | Sanofi India Limited has informed the Exchange regarding a press release dated April 28, 2026, titled "Sanofi India Limited continues to deliver strong performance in insulin portfolio". | nse |
| 28 Apr, 06:36 pm | — | … | Sanofi India Ltd - 500674 - Board Meeting Outcome for Of The Board Meeting Of The Company | bse |
| 28 Apr, 06:36 pm | — | … | Sanofi India Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | nse |
| 21 Apr, 06:33 pm | — | … | Sanofi India Limited has informed the Exchange about disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Refund Order | nse |
| 20 Apr, 02:54 pm | — | … | Sanofi India Ltd - 500674 - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The Quarter Ended 31St March 2026 | bse |
| 02 Apr, 08:08 pm | — | … | Sanofi India Limited has informed the Exchange about dispatched of letters to shareholders, providing the weblink and QR code for accessing the Notice of the 70th Annual General Meeting and Integrated Annual Report for the financial year ended 31st December 2025 | nse |
| 02 Apr, 08:04 pm | — | … | Sanofi India Limited has informed the Exchange about Communication of Tax Deduction at Source on Final Dividend for the Financial Year ended December 31, 2025 | nse |
| 02 Apr, 07:59 pm | — | … | Sanofi India Limited has informed the Exchange regarding 'Intimation Regarding Receipt Of Central Government Approval For Appointment Of The Managing Director Of The Company'. | nse |